Treatment‐related adverse events of antibody‐drug conjugates in clinical trials: A systematic review and meta‐analysis.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 5, p. 346, doi. 10.1002/cai2.97
- By:
- Publication type:
- Article
Works matching IS 27709183 AND DT 2023 AND VI 2 AND IP 5
Results: 9
1
2
Bioinformatics analysis of human kallikrein 5 (KLK5) expression in metaplastic triple‐negative breast cancer.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 5, p. 376, doi. 10.1002/cai2.96
- By:
- Publication type:
- Article
3
The road toward breast cancer single‐disease quality control in China.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 5, p. 319, doi. 10.1002/cai2.93
- By:
- Publication type:
- Article
4
Machine‐learning radiomics to predict bone marrow metastasis of neuroblastoma using magnetic resonance imaging.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 5, p. 405, doi. 10.1002/cai2.92
- By:
- Publication type:
- Article
5
Development and validation of a nomogram to predict cardiac death after radiotherapy for esophageal cancer.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 5, p. 391, doi. 10.1002/cai2.89
- By:
- Publication type:
- Article
6
Initial refinement of data from video‐based single‐cell tracking.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 5, p. 416, doi. 10.1002/cai2.88
- By:
- Publication type:
- Article
7
A case report of multimodal ultrasound imaging in the diagnosis of giant retroperitoneal ganglioneuroma.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 5, p. 433, doi. 10.1002/cai2.73
- By:
- Publication type:
- Article
8
Radiotherapy, photodynamic therapy, and cryoablation‐induced abscopal effect: Challenges and future prospects.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 5, p. 323, doi. 10.1002/cai2.53
- By:
- Publication type:
- Article
9
Issue Information.
- Published in:
- Cancer Innovation, 2023, v. 2, n. 5, p. 1, doi. 10.1002/cai2.17
- Publication type:
- Article